Immutep Limited

NASDAQ:IMMP

Biotechnology

Healthcare
$0.37 +0.64%

+$0.00 today

Market cap
$55.01M
Beta
2.24
P/E (TTM)
-0.9
EPS (TTM)
-$0.06
52W Low $0.29High $3.53

Volume 3.10M

Average 13.46M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$62.05M

FY 2025 · Annual

Investing Cash Flow

-$38.53M

FY 2025 · Annual

Financing Cash Flow

-$525,121.00

FY 2025 · Annual

Cash Flow Statement

AUD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income(29.9M)(32.21M)(39.9M)(42.72M)(61.43M)
Depreciation & Amortization2.07M2.06M2.06M2.26M2.39M
Deferred Income Tax(7.29M)0(4.99M)00
Stock-Based Compensation1.7M1.49M2M1.8M1.16M
Change in Working Capital(1.99M)(1.56M)764.6K3.46M(8.54M)
Accounts Receivables(2.83M)(2.25M)(1.61M)601.77K(2.52M)
Inventory0813.92K000
Accounts Payables1.38M1.44M3.27M00
Other Working Capital(543.42K)(1.56M)(900.11K)2.86M(6.02M)
Other Non-Cash Items17.77M(8.04K)4.17M379.87K4.37M
Operating Cash Flow(17.64M)(30.23M)(35.88M)(34.82M)(62.05M)
Capital Expenditures(15.6K)(22.91K)(47K)(932.37K)(45.77K)
Acquisitions (Net)00000
Purchases of Investments000(20.09M)0
Sales of Investments00000
Other Investing Activities0016K(903.15K)(38.49M)
Investing Cash Flow(15.6K)(22.91K)(31K)(21.02M)(38.53M)
Debt Repayment(214.38K)(222.54K)(211.97K)(226.49K)(270.67K)
Common Stock Issued43.31M52.98M80.08M100.24M(164.79K)
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities9.59M(2.43M)(3.83M)(4.83M)(254.46K)
Financing Cash Flow52.68M50.33M76.04M95.18M(525.12K)
Effect of Forex Changes(752.84K)(671.04K)3.3M(967.73K)6.73M
Net Change in Cash34.27M19.4M43.42M38.37M(94.38M)
Free Cash Flow(17.66M)(30.25M)(35.93M)(35.75M)(62.1M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$61.4M
+ D&A$2.4M
+ Stock-Based Comp$1.2M
+ Deferred Tax$0
- Working Capital-$8.5M
+ Other Non-Cash$4.4M
= Operating Cash Flow-$62.0M
- Capex-$45.8K
= Free Cash Flow-$62.1M

Analysis

FY2025 free cash flow is -$62.1M. FCF conversion is 101.1% of net income. Operating cash flow was -$62.0M, with capex of -$45.8K. The largest bridge item is Working Capital at -$8.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingSep 11, 2026
6-K6-K filingSep 2, 2026
6-K6-K filingAug 3, 2026
6-K6-K filingJul 14, 2026
6-K6-K filingJun 5, 2026

Does IMMP generate free cash flow?

Immutep Limited (IMMP) generated -$62.10M of free cash flow in fiscal 2025.

How much operating cash flow does IMMP produce?

Operating cash flow was -$62.05M, before capital expenditures of $45,769.00.